Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 56.30B | 54.06B | 52.55B | 48.88B | 45.91B |
Gross Profit | 6.61B | 6.97B | 6.41B | 6.57B | 6.47B |
EBITDA | 3.60B | 4.32B | 3.84B | 3.92B | 3.45B |
Net Income | 1.49B | 2.01B | 1.71B | 1.84B | 1.49B |
Balance Sheet | |||||
Total Assets | 30.48B | 30.99B | 29.53B | 27.49B | 26.01B |
Cash, Cash Equivalents and Short-Term Investments | 7.19B | 8.02B | 6.69B | 5.61B | 5.78B |
Total Debt | 4.41B | 5.20B | 6.54B | 5.61B | 6.08B |
Total Liabilities | 13.62B | 14.92B | 14.89B | 13.84B | 13.76B |
Stockholders Equity | 16.87B | 16.07B | 14.65B | 13.66B | 12.25B |
Cash Flow | |||||
Free Cash Flow | 936.13M | 2.97B | 758.42M | 1.15B | 1.12B |
Operating Cash Flow | 1.72B | 3.96B | 2.00B | 2.57B | 2.28B |
Investing Cash Flow | -993.75M | -715.48M | -1.12B | -1.61B | -691.61M |
Financing Cash Flow | -1.56B | -1.91B | 198.58M | -1.14B | -2.02M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥9.32B | 11.49 | 2.57% | 29.34% | 68.31% | ||
78 Outperform | ¥20.05B | 11.45 | 3.81% | 4.31% | -9.01% | ||
71 Outperform | ¥9.59B | 13.64 | 1.26% | 18.30% | 37.13% | ||
67 Neutral | ¥9.25B | 26.90 | ― | 11.69% | -38.92% | ||
66 Neutral | ¥10.37B | 19.20 | 1.22% | 20.37% | -5.97% | ||
57 Neutral | ¥30.99B | 159.73 | 2.67% | 20.41% | -251.04% | ||
51 Neutral | $7.69B | -0.19 | -46.01% | 2.25% | 22.94% | -0.68% |